A detailed history of Ares Financial Consulting, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ares Financial Consulting, LLC holds 509 shares of ABT stock, worth $66,185. This represents 0.06% of its overall portfolio holdings.

Number of Shares
509
Holding current value
$66,185
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
$123.62 - $134.59 $62,922 - $68,506
509 New
509 $63.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ares Financial Consulting, LLC Portfolio

Follow Ares Financial Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ares Financial Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ares Financial Consulting, LLC with notifications on news.